Procalcitonin is an independent predictor for coronary atherosclerotic burden in patients with stable coronary artery disease


Kurtul A., Elcik D.

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.236, ss.61-64, 2017 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 236
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.ijcard.2017.02.061
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOLOGY
  • Sayfa Sayısı: ss.61-64

Özet

Objectives: Higher coronary atherosclerotic burden has been associated with increased cardiovascular events including mortality. The SYNTAX score (SXs) reflects coronary atherosclerotic burden. Given the body of evidence implicating inflammation in atherosclerotic process, we hypothesized that procalcitonin (PCT) as an inflammatory marker may be related to coronary atherosclerotic burden. Thus, we aimed to investigate the relationship between serum PCT levels and SXs in patients with stable CAD.